Research ArticleDrug Discovery and Translational Medicine
3,5-Dihydroxybenzoic Acid, a Specific Agonist for Hydroxycarboxylic Acid 1, Inhibits Lipolysis in Adipocytes
Changlu Liu, Chester Kuei, Jessica Zhu, Jingxue Yu, Li Zhang, Amy Shih, Taraneh Mirzadegan, Jonathan Shelton, Steven Sutton, Margery A. Connelly, Grace Lee, Nicholas Carruthers, Jiejun Wu and Timothy W. Lovenberg
Journal of Pharmacology and Experimental Therapeutics June 2012, 341 (3) 794-801; DOI: https://doi.org/10.1124/jpet.112.192799
Changlu Liu
Chester Kuei
Jessica Zhu
Jingxue Yu
Li Zhang
Amy Shih
Taraneh Mirzadegan
Jonathan Shelton
Steven Sutton
Margery A. Connelly
Grace Lee
Nicholas Carruthers
Jiejun Wu
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
3,5-Dihydroxybenzoic Acid as a Specific Agonist for HCA1
Changlu Liu, Chester Kuei, Jessica Zhu, Jingxue Yu, Li Zhang, Amy Shih, Taraneh Mirzadegan, Jonathan Shelton, Steven Sutton, Margery A. Connelly, Grace Lee, Nicholas Carruthers, Jiejun Wu and Timothy W. Lovenberg
Journal of Pharmacology and Experimental Therapeutics June 1, 2012, 341 (3) 794-801; DOI: https://doi.org/10.1124/jpet.112.192799
Research ArticleDrug Discovery and Translational Medicine
3,5-Dihydroxybenzoic Acid as a Specific Agonist for HCA1
Changlu Liu, Chester Kuei, Jessica Zhu, Jingxue Yu, Li Zhang, Amy Shih, Taraneh Mirzadegan, Jonathan Shelton, Steven Sutton, Margery A. Connelly, Grace Lee, Nicholas Carruthers, Jiejun Wu and Timothy W. Lovenberg
Journal of Pharmacology and Experimental Therapeutics June 1, 2012, 341 (3) 794-801; DOI: https://doi.org/10.1124/jpet.112.192799
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement